Published Date: 13 Mar 2023
Canada: Long-term COVID-19 associated with psychiatric symptoms and cognitive impairment, research recently published in the journal Brain, Behavior,...
Read Full NewsPatients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
1.
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC
2.
In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.
3.
Which women need more than mammograms for breast cancer screening?
4.
African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis
5.
Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds
1.
A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis
2.
Know About Lymphangioma: Symptoms, Causes, and Treatments
3.
The Unseen Threat: Uncovering the Risks of Pancoast Tumor
4.
Understanding the Rare Disease: Werner Syndrome Explained
5.
Angina Haemorrhagica Bullosa: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part IX
4.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
5.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation